References
- 통계청. 2004년도 사망원인통계결과, 서울. 통계청, pp 13-15, 2005
- 김 병, 문 구. 위암의 동서의학적 진치개황. 대한한의학회지. 17(2):100-116, 1996
- 윤성우, 유봉하, 박동원, 유기원. 위암이 동의학 및 동서의 결합치료에 관한 문헌적 고찰. 대한종양학회지. 2(1):177-192, 1996
- 김성훈. 韓醫學界의 癌硏究動向과 硏究戰略에 대한 연구. 대한한의학회지. 19(1):470-499, 1998
- 김동희, 김성훈. 抗癌劑 및 放射線 副作用에 대한 韓方療法. 동의병리학회지. 9:239-264, 1994
- 안덕균. 한국본초도감. 서울. 교학사, p 729, 2003
- Jung, N.C. Biological activity of urushiol and flavonoids from Lac tree (Rhus verniciflua Stokes). Ph.D. Thesis, Chonnam National University, Kwang-ju, South Korea, 1998
- Lee, J.C., Kim, J., Lim, K.T., Yang, M.S. and Jang, Y.S. Ethanol eluted extract of Rhus verniciflua Stokes showed both antioxidant and cytotoxic effects on mouse thymocytes depending on the dose and time of the treatment. Journal of Biochemistry and Molecular Biology. 34:250-258, 2001
- Lee, J.C., Lim, K.T. and Jang, Y.S. Identification of Rhus verniciflua Stokes compounds that exhibit free radical scavenging and anti-apoptotic properties. Biochimica et Biophysica Acta., 1570:181-191, 2002 https://doi.org/10.1016/S0304-4165(02)00196-4
- Kitts, D.D., and Lim, K. TAntitumorigenic and cytotoxic properties of an ethanol extract derived from Rhus verniciflua Stokes (乾漆). Journal of Toxicology and Environmental Health Part A. 64:357-371, 2001 https://doi.org/10.1080/152873901316981330
- Lee, J.C., Kim, J. and Jang, Y.S. Ethanol-eluted extract of Rhus verniciflua stokes inhibits cell growth and induces apoptosis in human lymphoma cells. J Biochem Mol Biol.. 4:337-343, 2003
- Lee, J.C., Lee, K.Y., Kim, J.N., et al. Extract from Rhus verniciflua Stokes is capable of inhibiting the growth of human lymphoma cells. Food Chem Toxicol. 9:1383-1388, 2004
- Meier, P., Finch, A. and Evan, G. Apoptosis in development. Nature. 407:796-801, 2000 https://doi.org/10.1038/35037734
- Jonstone, R.W. Apoptosis: a link between cancer genetics and chemotherapy. Cell. 108:153-164, 2002 https://doi.org/10.1016/S0092-8674(02)00625-6
- Green, D.R. Apoptotic pathways: paper wraps stone blunts scissors. Cell. 102:1-4, 2000 https://doi.org/10.1016/S0092-8674(00)00003-9
- Kothakota, S., Azuma, T., Reinhard, C. et al. Caspase- 3-generated fragment of gelsolin: Effector of morphological change in apoptosis. Science. 278:294-298, 1997 https://doi.org/10.1126/science.278.5336.294
- Nunez, G., Benedict, M.A., Hu, Y. and Inohara, N. Caspases: The proteases of the apoptotic pathway. Oncogene. 17:3237-3245, 1998 https://doi.org/10.1038/sj.onc.1202581
- Adams, J.M. and Cory, S. The Bcl-2 protein family: arbiters of cell survival. Science. 281:1322-1326, 1998 https://doi.org/10.1126/science.281.5381.1322
- Atan, G., James, M.M. and Stanley, J.K. Bcl-2 family members and the mitochondria in apoptosis. Genes. Dev. 13:1899-1911, 1999 https://doi.org/10.1101/gad.13.15.1899
- Nasmyth, K. Viewpoint: putting the cell cycle in order. Science. 274:1643-1645, 1996 https://doi.org/10.1126/science.274.5293.1643
- Sherr, C.J. and Roberts, J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev.. 12:1501-1121, 1999.
- Polyak, K., Kato, J.Y., Solomon, M.J., Sherr, C.J., Massague, J., Roberts, J.M., and Koff, A. P27 KIP1, a cyclin Cdk inhibitor, links transforming growth factor beta and contact inhibition to cell cycle arrest. Genes Dev. 8:9-22, 1994 https://doi.org/10.1101/gad.8.1.9
- Toyoshima, H. and Hunter, T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.Cell. 78:67-74, 1994 https://doi.org/10.1016/0092-8674(94)90573-8
- Coats, S., Flanagen, M., Nourse, J., and Roberts, J.M. Requirement of p27kip1 for restriction point control of the fibroblast cell cycle. Science. 272:877-880, 1996 https://doi.org/10.1126/science.272.5263.877
- Coqueret, O. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment Trends. Cell Biol. 2:65-70, 2003
- Elledge, S.J. and Harper, J.W. The role of protein stability in the cell cycle and cancer. Biochim. Biophys. Acta. 1377:M61-M70, 1998
- Pagano, M., Tam, S.W., Theodoras, A.M. et al. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science (Wash. DC). 269:682-685, 1995 https://doi.org/10.1126/science.7624798
- Schulman, B.A., Carrano, A.C., Jeffrey, P.D. et al. Insights into SCF ubiquitin ligases from the structure of the Skp1-Skp2 complex. Nature (Lond.). 408:381-386, 2000 https://doi.org/10.1038/35042620
- Carrano, A.C., Eytan, E., Hershko, A. and Pagano, M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat. Cell Biol. 1:193-199, 1999. https://doi.org/10.1038/12013
- Sutterluty, H., Chatelain, E., Marti, A., Wirbelauer, C., Senften, M., Muller, U. and Krek, W. p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nat. Cell Biol. 1:207-214, 1999 https://doi.org/10.1038/12027
- Tsvetkov, L.M., Yeh, K.H., Lee, S.J., Sun, H. and Zhang, H. p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr. Biol. 9:661-664, 1999 https://doi.org/10.1016/S0960-9822(99)80290-5
- Nakayama, K.I., Hatakeyama, S. and Nakayama, K. Regulation of the cell cycle at the G1-S transition by proteolysis of cyclin E and p27Kip1. Biochem Biophys Res Commun. 4:853-860, 2001
- Masuda, T.A., Inoue, H., Sonoda, H. et al. Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis. Cancer Res. 13:3819-3825, 2002
- Nevins, J.R. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science. 258:424-429, 1992 https://doi.org/10.1126/science.1411535
- Flemington, E.K., Speck, S.H., and Kaelin, Jr. W.G. E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc. Natl. Acad. Sci. USA, 90:6914-6918, 1993
- Helin, K., Harlow, E. and Fattaey, A.R. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol. Cell. Biol. 13:6501-6508, 1993 https://doi.org/10.1128/MCB.13.10.6501
- Humbert, P.O., Verona, R., Trimarchi, J.M., Rogers, C., Dandapani, S. and Lees, J.A. E2F3 is critical for normal cellular proliferation. Genes Dev. 14:690-703, 2000
- Dalton, S. Cell cycle regulation of the human cdc2 gene. EMBO J. 11:1797-1804, 1992
- Sheaff, R.J., Groudine, M., Gordon, M., Roberts, J.M. and Clurman, B.E. Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev.. 11:1464-1478, 1997 https://doi.org/10.1101/gad.11.11.1464
- Vlach, J., Hennecke, S., and Amati, B. Phosphorylation- dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1. EMBO J., 16:5334-5344, 1997 https://doi.org/10.1093/emboj/16.17.5334
- Lloyd, R.V., Erickson, L.A., Jin, L. et al. p27kip1: a multifunctional cyclin dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol., 2:313-323, 1999
- Stacy, W.B. p27 as a target for cancer therapeutics. Cancer cell. 3:111-115, 2003 https://doi.org/10.1016/S1535-6108(03)00026-6
- Masuda, T.A., Inoue, H., Sonoda, H. et al. Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis. Cancer Res. 13:3819-3825, 2002